SpyGlass Pharma (SGP) Income Statement

31 Followers

SpyGlass Pharma Income Statement

Last quarter (Q2 2026), SpyGlass Pharma's total revenue was $0.00, a decrease of ― from previous quarter. In Q2, SpyGlass Pharma's net income was $-19.86M. See SpyGlass Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ -612.00K
Operating Expenses	$ 40.84M
Depreciation and Amortization	$ 612.00K
EBITDA	$ -39.26M
Operating Income	$ -41.45M
Other Income/Expenses	$ 1.58M
Pretax Income	$ -39.87M
Net Income	$ -39.87M
Per Share Metrics
Basic EPS	$ -1.25
Diluted EPS	$ -1.25
Weighted Average Shares Outstanding	31.91M
Weighted Average Shares Outstanding (Diluted)	31.91M

Currency in USD

SpyGlass Pharma (SGP) Income Statement

SpyGlass Pharma Income Statement

SpyGlass Pharma Earnings and Revenue History